Skip to main content
. 2022 May 24;72(719):e430–e436. doi: 10.3399/BJGP.2021.0581

Table 3.

Number of patients with a prescription for intermediate and long-acting insulins

Type of insulin All patients, n (%) (n= 7757) Insulin-naive patients, n (%) (n= 1159)
Newer insulins 1983 (25.6) 282 (24.3)
Glargine 300 U/ml 895 (11.5) 120 (10.4)
Degludec 1088 (14.0) 162 (14.0)

Other insulins 5774 (74.4) 877 (75.7)
NPH-insulin 1330 (17.1) 303 (26.1)
Glargine 100 U/ml 3516 (45.3) 501 (43.2)
Detemir 928 (12.0) 73 (6.3)